MCID: VRL004
MIFTS: 23

Viral Labyrinthitis

Categories: Ear diseases, Infectious diseases, Neuronal diseases

Aliases & Classifications for Viral Labyrinthitis

MalaCards integrated aliases for Viral Labyrinthitis:

Name: Viral Labyrinthitis 12 74
Vestibular Neuronitis 74
Epidemic Vertigo 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12357
ICD9CM 36 386.35
SNOMED-CT 69 34243007
ICD10 34 A88.1

Summaries for Viral Labyrinthitis

Disease Ontology : 12 A labyrinthitis which involves viral infection of the inner ear through the upper airway or the blood stream. The symptoms may include hearing loss and ringing in the ears. If the virus reaches the vestibular system, dizziness, severe vertigo with nausea and vomiting, and imbalance can occur.

MalaCards based summary : Viral Labyrinthitis, also known as vestibular neuronitis, is related to labyrinthitis and vestibular neuronitis. The drugs Prednisolone phosphate and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include bone and endothelial.

Related Diseases for Viral Labyrinthitis

Diseases in the Labyrinthitis family:

Viral Labyrinthitis

Diseases related to Viral Labyrinthitis via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 labyrinthitis 10.5
2 vestibular neuronitis 10.4
3 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9
4 sensorineural hearing loss 9.9
5 neuritis 9.9
6 encephalitis 9.9
7 sudden sensorineural hearing loss 9.9

Comorbidity relations with Viral Labyrinthitis via Phenotypic Disease Network (PDN):


Hypertension, Essential Ischemic Heart Disease
Labyrinthitis Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Viral Labyrinthitis:



Diseases related to Viral Labyrinthitis

Symptoms & Phenotypes for Viral Labyrinthitis

Drugs & Therapeutics for Viral Labyrinthitis

Drugs for Viral Labyrinthitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 38)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Not Applicable 302-25-0
2
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 50-24-8 5755
3
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 83-43-2 6741
4
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Not Applicable 2921-57-5
5
Betamethasone Approved, Vet_approved Phase 4 378-44-9 9782
6
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Not Applicable 2920-86-7
7 Prednisolone acetate Phase 4,Phase 3,Not Applicable
8 Peripheral Nervous System Agents Phase 4,Phase 3,Not Applicable
9 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Not Applicable
10 Hormones Phase 4,Phase 3,Phase 2,Not Applicable
11 Autonomic Agents Phase 4,Phase 3,Not Applicable
12 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Not Applicable
13 Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
14 Antiemetics Phase 4,Phase 3,Not Applicable
15 Methylprednisolone Acetate Phase 4,Phase 3,Not Applicable
16 Neuroprotective Agents Phase 4,Phase 3,Not Applicable
17 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
18 glucocorticoids Phase 4,Phase 3,Phase 2,Not Applicable
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Not Applicable
20 Protective Agents Phase 4,Phase 3,Not Applicable
21 Betamethasone-17,21-dipropionate Phase 4
22 Anti-Asthmatic Agents Phase 4,Phase 3
23 Betamethasone sodium phosphate Phase 4
24 Betamethasone benzoate Phase 4
25 Betamethasone Valerate Phase 4 2152-44-5
26 Respiratory System Agents Phase 4,Phase 3
27
Cilostazol Approved, Investigational Phase 3 73963-72-1 2754
28 Ginkgo Phase 3
29 Vasodilator Agents Phase 3
30 Fibrinolytic Agents Phase 3
31 Phosphodiesterase 3 Inhibitors Phase 3
32 Bronchodilator Agents Phase 3
33 Platelet Aggregation Inhibitors Phase 3
34 Phosphodiesterase Inhibitors Phase 3
35
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
36
Dexamethasone Approved, Investigational, Vet_approved Early Phase 1 50-02-2 5743
37
Dexamethasone acetate Approved, Investigational, Vet_approved Early Phase 1 1177-87-3
38 BB 1101 Early Phase 1

Interventional clinical trials:

(show all 21)
# Name Status NCT ID Phase Drugs
1 Acute Unilateral Vestibulopathy and Corticosteroid Treatment Recruiting NCT02912182 Phase 4 Betamethasone;Placebo;Prednisolone
2 The Efficacy of Steroid Therapy in Vestibular Neuritis Completed NCT02098330 Phase 3 Ginkgo biloba & Methylprednisolone;Ginkgo biloba
3 Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy Terminated NCT01895400 Phase 3 Renexin (cilostazol 100mg + gingko biloba extract 80 mg);Placebo
4 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2 Prednisone;Prednisone
5 Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System Completed NCT00032383 Phase 1, Phase 2
6 Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation Not yet recruiting NCT03846830 Phase 2
7 The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis Unknown status NCT01231009 Early Phase 1 Corticosteroids
8 Characterisation of Cortical Vestibular Evoked Potentials (C-VEPs) Unknown status NCT02463695 Not Applicable
9 Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials Unknown status NCT03049683
10 Vestibular System in Migrainous Vertigo Patients Unknown status NCT00901953
11 Game Based Vestibular Exercise for Home Rehabilitation Unknown status NCT02134444 Not Applicable
12 Recovery of Visual Acuity in People With Vestibular Deficits Completed NCT00411216 Not Applicable
13 Home-based Computer Gaming in Vestibular Rehabilitation Completed NCT01943955 Not Applicable
14 Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool Completed NCT02171312
15 Spatial Orientation and Vestibular Function Completed NCT02212847 Not Applicable
16 To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics. Completed NCT02213120
17 MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla Recruiting NCT03452410
18 Does Vestibular Rehabilitation Significantly Improve the Level of Vestibular Function Following Vestibular Neuritis? Recruiting NCT03821155 Not Applicable Corticosteroid
19 Assessment and Treatment of Patients With Long-term Dizziness in Primary Care Recruiting NCT02655575 Not Applicable
20 Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) Recruiting NCT02483429 Not Applicable
21 Vestibulopathy With Vestibulo Ocular Reflex (VOR) Gain Deficit Not yet recruiting NCT03271775 Not Applicable

Search NIH Clinical Center for Viral Labyrinthitis

Genetic Tests for Viral Labyrinthitis

Anatomical Context for Viral Labyrinthitis

MalaCards organs/tissues related to Viral Labyrinthitis:

42
Bone, Endothelial

Publications for Viral Labyrinthitis

Articles related to Viral Labyrinthitis:

(show all 14)
# Title Authors Year
1
Steroids for Acute Vestibular Neuronitis-the Earlier the Treatment, the Better the Outcome? ( 30681432 )
2019
2
Horizontal vestibulo-ocular reflex dynamics in acute vestibular neuritis and viral labyrinthitis: evidence of otolith-canal interaction. ( 14977076 )
2004
3
Viral theory for MAcniA"re's disease and endolymphatic hydrops: overview and new therapeutic options for viral labyrinthitis. ( 9616689 )
1997
4
Development of high endothelial venule-like characteristics in the spiral modiolar vein induced by viral labyrinthitis. ( 8395627 )
1993
5
Recovery of the vestibular function after vestibular neuronitis. ( 8470496 )
1993
6
Comparative experimental viral labyrinthitis. ( 2177958 )
1990
7
Idiopathic sudden sensorineural hearing loss and postnatal viral labyrinthitis: a statistical comparison of temporal bone findings. ( 2244729 )
1990
8
Faint palatal rash and viral labyrinthitis. ( 2893203 )
1988
9
Viral labyrinthitis/encephalitis: Marondera area. ( 3607864 )
1986
10
Viral labyrinthitis: early pathology in the human. ( 6606097 )
1983
11
Viral labyrinthitis -- an experimental study. ( 1124905 )
1975
12
Experimental viral labyrinthitis. ( 1118012 )
1975
13
Viral labyrinthitis and transient phrenic nerve paralysis. ( 4144300 )
1973
14
Viral labyrinthitis--histopathologic characteristics. ( 6032377 )
1967

Variations for Viral Labyrinthitis

Expression for Viral Labyrinthitis

Search GEO for disease gene expression data for Viral Labyrinthitis.

Pathways for Viral Labyrinthitis

GO Terms for Viral Labyrinthitis

Sources for Viral Labyrinthitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....